Introduction

Impetigo is caused by gram-positive bacteria and it is one of the common skin infections.

About 90% of cases of bullous impetigo are caused by children younger than 2 years. Epidemiology Nonbullous impetigo is primarily caused by S aureus, which is responsible for 80% of cases. The cause of bullous impetigo is almost exclusively S aureus. Occasionally, a severe ulcerated infection, commonly referred to as ecthyma, may arise, a complication of bullous impetigo. Impetigo is a secondary infection caused by insect bites, eczema, or herpes lesions. Impetigo caused only by S. aureus causes large, relaxed blisters and is more likely to affect the interstitial area. Oral antibiotic therapy can be used for impotence with large blisters, or when topical therapy is not practical.^{1, 2}

Understanding impetigo

Impetigo is a condition that causes reddish sores around the nose and mouth, often around the nose and mouth. The sores eventually rupture and ooze for a few days, and then develop a honey-colored crust. The itch and soreness are usually mild.³ There are three types of impetigo viz. Bullous, non-bullous, and ecthyma.

Impetigo symptoms and complications

Typical symptoms of impetigo

• Non-bullous or crusted is most common. It begins with tiny blisters that eventually burst, leaving small wet patches of red skin that may weep fluid. The area gradually develops a yellowish-brown or tan crust, which looks like it has been coated with honey or brown sugar
• Bullous impetigo causes larger, fluid-containing blisters that look clear and then cloudy. These types of blisters are more likely to remain longer on the skin without bursting. 
• Ecthyma impetigo appears as a "punched out" ulcer with a yellow crust and red edges⁴

Common complications associated with impetigo

1. Post-streptococcal glomerulonephritis is a rare, acute renal condition following an infection with Streptococcus pyogenes (group A streptococcus) This is attributed to a type III hypersensitivity reaction that manifests itself 2-6 weeks post-skin infection 
2. Streptococcal toxic shock syndrome is a rare complication causing a diffuse erythematous rash, hypotension, and pyrexia 
3. Postinflammatory pigmentation is associated with post-inflammatory pigmentation. Scarring, especially with ecthyma, is common⁵

Fever in impetigo: what it indicates

The lesion of streptococcal pyoderma commences as a papule that swiftly transforms into a vesicle, encircled by an area of erythema. Vesicular lesions are evanescent and are rarely clinically recognized. They give rise to pustules that gradually enlarge and then break down over a few days to form thick crusts. The lesions undergo a gradual healing process and result in the formation of depigmented areas. A deeply ulcerated form of impetigo, known as ecthyma 

Lower extremities or face are commonly seen with Streptococcal impetigo. Despite the possibility of regional lymphadenitis, systemic symptoms are typically absent. Previously, the lesions previously described were confidently diagnosed as streptococcal. This was the predominant form of impetigo, which was distinguishable from bullous impetigo caused by phage group II S. aureus. 

Even though bullous impetigo remains primarily caused by staphylococcus, the bacteriology of non-bullous impetigo has changed. S. aureus, either alone or in conjunction with S. pyogenes, is currently the predominant causative agent. Almost all of these staphylococci are capable of producing penicillinase. Penicillin, which was previously highly effective against non-bullous impetigo, is now often unsuccessful, even when both streptococci and staphylococci are isolated from the lesions. 

The evaluation of anti-streptolysin O (ASO) antibodies is ineffective in the diagnosis and management of impetigo, as the ASO response is insufficient in patients with streptococcal impetigo, presumably due to the inhibition of streptolysin O's activity by skin lipids (cholesterol) In contrast, anti-DNase B levels are elevated, which provides helpful supporting evidence of recent streptococcal infection in patients who are suspected of having post-streptococcal glomerulonephritis.⁶

Diagnosis and treatment

How impetigo with fever is diagnosed

Bacterial societies can be utilized for affirmation of determination and ought to be obtained if methicillin-resistant staph aureus (MRSA) is suspected or if an impetigo flare-up is present.

However, it may be valuable if post-streptococcal glomerulonephritis is suspected in a quiet with a later impetigo outbreak. Therefore, serologic testing for streptococcal antibodies is not demonstrated for the determination of impetigo.

Human immunodeficiency infection (HIV) testing ought to be considered when an already sound grown-up creates bullous impetigo. Although impetigo is frequently self-limiting, antimicrobials can diminish the term of ailment and spread of lesions. It is basic to completely clean hands, clothes, clothing, and any influenced regions that may have come into contact with contaminated fluids. 

Treatment options for impetigo and managing fever

Treatment options for impetigo and managing fever include treatment options for impetigo and fever management.

Impetigo is treated with topical antibiotics alone or in combination with systemic antibiotics. The coverage of antibiotics ought to encompass both S aureus and S pyogenes, specifically GABHS. Although impetigo is often self-limiting, antibiotics can reduce the duration of illness and spread of lesions. Furthermore, the administration of antibiotics reduces the likelihood of complications involving the kidneys, joints, bones, and lungs, as well as acute rheumatic fever. 

The treatment of choice for impetigo that is localized, uncomplicated, and non-bullous is solely topical therapy. Before applying topical antibiotic therapy, it is important to remove the crust with soap and water. Systemic antibiotics should be prescribed for all cases of bullous impetigo and non-bullous impetigo that involve more than five lesions, deep tissue involvement, systemic signs of infection, lymphadenopathy, or lesions in the oral cavity. Beta-lactamase-resistant antibiotics, such as cephalosporins are the preferred treatment option. If a culture confirms a solely streptococcal infection, oral penicillin is the preferred treatment. In areas of high prevalence of MRSA or if cultures are positive for MRSA, clindamycin or doxycycline are preferred treatments. 

Trimethoprim-sulfamethoxazole is viable against MRSA, but it ought to be utilized as it were if bunch A streptococci are not the causative operator, or in expansion to an anti-streptococcal anti-microbial. Children diagnosed with impetigo are advised to practice good personal hygiene and refrain from socializing with other children during the active outbreak. If impetigo is recurrent, it is important to evaluate for the presence of the causative bacteria. The nose is a common reservoir and can be treated with mupirocin (Bactroban Nasal), which is applied to the nostrils.⁷

Prevention and prognosis

It is important to prevent impetigo from spreading. For example, if your child has a runny nose, you should keep the area between the upper lip and nose clean. The nose frequently serves as the reservoir for impetigo germs. Physicians advise applying a thin layer of antibacterial ointment under the nose and in the nostrils with a Q-tip. These measures have the potential to eradicate the pathogenic bacteria responsible for the infection.⁸

Summary

There are 3 Types of impetigo: bullous, non-bullous, and ecthyma Typical symptoms of impetigo Non-bullous or crusted impetigo are most common. Although bullous impetigo remains almost exclusively caused by staphylococcus, the bacteriology of non-bullous impetigo has changed.

History and physical exams are essential to the diagnosis of impetigo. Human immunodeficiency virus testing should be taken into account when an adult who had previously been in good health develops bullous impetigo B. Treatment options for impetigo and managing fever include the use of topical antibiotics either alone or in conjunction with systemic antibiotics. Systemic antibiotics should be prescribed for all cases of bullous impetigo and non-bullous impetigo that involve more than five lesions, deep tissue involvement, systemic signs of infection, lymphadenopathy, or lesions in the oral cavity.